Blog
RSS FeedPosted by Michael Wonder on 07 Oct 2022
Pembrolizumab in combination with platinum-based chemotherapy for treating recurrent, persistent or metastatic cervical cancer
5 October 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
Posted by Michael Wonder on 23 Jul 2017
Tackling submission and publication bias
17 July 2017 - Evoniuk and colleagues analysed whether submission and publication bias are based on study outcome. ...
Posted by Michael Wonder on 22 Mar 2017
NICE terminates four single technology assessments
22 March 2017 - Appraisals terminated as a result of four sponsors deciding not to submit evidence. ...